Forbes contributors publish independent expert analyses and insights. Shaping the future of banking with bitcoin. (Full disclosure: I’m helping build Coinbits.app, a bitcoin banking platform.) In a ...
Controversial Securities and Exchange Commission accounting guidance known as SAB 121 has been rescinded. SAB 121 has been viewed as a significant obstacle preventing banks from providing custody ...
SIOUX FALLS, S.D.--(BUSINESS WIRE)--SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, ...
SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.
Sets Stage for Public Debut of SAB, Whose Unique Immunotherapy Platform Produces Targeted, High-Potency Fully-Human Polyclonal Antibodies Without the Need for Human Donors MIAMI, Oct. 21, 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results